“avexis” Archives

in
Entry Author Date Location
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI 12/03/19 San Diego
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns 10/30/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market 08/06/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Report: Biogen, Novartis Should Drop Prices of Billon-Dollar SMA Drugs 04/04/19 Boston
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy 02/25/19 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Novartis Buys Endocyte for $2.1B, Making a Second Bet on Radiotherapy 10/18/18 Indiana
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow 04/25/18 Boston
Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs 04/20/18 Boston
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
As Novartis Buys In to Gene Therapy, GSK Bows Out with Orchard Deal 04/12/18 Boston
Novartis Bets $8.7B on AveXis’s Gene Therapy for Spine Disease 04/09/18 National
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety 01/30/18 National
Page 1 of 2 next page »